CAS 1257051-63-0

THPP-1

CAS : 1257051-63-0

THPP-1

Formule : C₂₃H₂₁ClN₆O₃

Degré de pureté : ≥98%

Masse moléculaire : 464.9

Ref: 54-BUP10837

THPP-1

CAS : 1257051-63-0

(2-(6-Chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)(imidazo[1,5-a]pyridin-1-yl)methanone

Formule : C₂₃H₂₁ClN₆O₃

Degré de pureté : 98%

Masse moléculaire : 464.9

Ref: IN-DG01222425

THPP-1

CAS : 1257051-63-0

THPP-1 is a potent and orally bioavailable inhibitor of PDE10A(Ki of 1 nM and 1.3 nM for human and rat PDE10A, respectively).

Formule : C₂₃H₂₁ClN₆O₃

Degré de pureté : 99.46%

Couleur et forme : Solid

Masse moléculaire : 464.9

Ref: TM-T8506

THPP-1

CAS : 1257051-63-0

THPP-1 is a potential mechanism for Parkinson's disease. It has been shown to have dose-dependent effects on rat striatal dopamine levels and may act as a prodrug of dopamine. THPP-1 also inhibits the activity of cyclic nucleotide phosphodiesterases, which are enzymes that break down cyclic nucleotides, such as adenosine monophosphate (AMP) and cyclic guanosine monophosphate (cGMP). This inhibition leads to an increase in intracellular cAMP and cGMP levels. THPP-1 has been expressed in the striatum of mice and rats, suggesting that it may be effective in treating Parkinson's disease when administered orally.

Formule : C₂₃H₂₁ClN₆O₃

Degré de pureté : Min. 95%

Masse moléculaire : 464.9 g/mol

Ref: 3D-HAC05163